The neurobiological context of autism

Autistic disorder (AD) is a complex neuropsychiatric disorder of neurodevelopmental origin, where multiple genetic and environmental factors may interact, resulting in a clinical continuum. The genetic component is best described by a multilocus model that takes into account epistatic interactions between several susceptibility genes. In the past ten years enormous progress has been made in identifying chromosomal regions in linkage with AD, but moving from chromosomal regions to candidate genes has proven to be tremendously difficult. Neuroanatomical findings point to early dysgenetic events taking place in the cerebral cortex, cerebellum, and brainstem. At the cellular level, disease mechanisms may include altered cell migration, increased cell proliferation, decreased cell death, or altered synapse elimination. Neurochemical findings in AD point to involvement of multiple neurotransmitter systems. The serotoninergic system has been intensively investigated in AD, but other neurotransmitter systems (e.g., the GABAergic and the cholinergic system) are also coming under closer scrutiny. The role of environmental factors is still poorly characterized. It is not clear yet whether environmental factors act merely as precipitating agents, always requiring an underlying genetic liability, or whether they represent an essential component of a pathogenetic process where genetic liability alone does not lead to the full-blown autism phenotype. A third potential player in the pathogenesis of autism, in addition to genetic and environmental factors, is developmental variability due to “random” factors, e.g. small fluctuations of gene expression and complex, non-deterministic interactions between genes during brain development. These considerations suggest that a non-deterministic conceptual framework is highly appropriate for autism research.

[1]  Stephen B. Dunnett,et al.  Transgenic mouse models of Alzheimer's disease , 2005 .

[2]  B Horwitz,et al.  The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. , 1988, Archives of neurology.

[3]  K. D. Tran,et al.  Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. , 1998, The American journal of psychiatry.

[4]  J. Christiansen,et al.  Targeted disruption of the Wnt2 gene results in placentation defects. , 1996, Development.

[5]  M. Ghaziuddin,et al.  Is megalencephaly specific to autism? , 1999, Journal of intellectual disability research : JIDR.

[6]  D. Cohen,et al.  Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[7]  T. Wassink,et al.  Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder , 2001, Molecular Psychiatry.

[8]  A. Persico,et al.  Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children , 2002, Molecular Psychiatry.

[9]  Ruth A. Carper,et al.  Unusual brain growth patterns in early life in patients with autistic disorder , 2001, Neurology.

[10]  B. Leventhal,et al.  The serotonin system in autism. , 1996, Current opinion in pediatrics.

[11]  D. Amaral,et al.  Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions , 2001, Neuroscience.

[12]  T. Kemper,et al.  The contribution of neuropathologic studies to the understanding of autism. , 1993, Neurologic clinics.

[13]  U. Wolf.  Identical mutations and phenotypic variation , 1997, Human Genetics.

[14]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[15]  C. Gillberg,et al.  Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders , 1993, Biological Psychiatry.

[16]  J. Sweatt,et al.  Reelin and ApoE Receptors Cooperate to Enhance Hippocampal Synaptic Plasticity and Learning* , 2002, The Journal of Biological Chemistry.

[17]  C Martin-Ruiz,et al.  Nicotinic receptor abnormalities in the cerebellar cortex in autism. , 2002, Brain : a journal of neurology.

[18]  R. Katzman.,et al.  Neurobiology of Autism , 1998, Annals of neurology.

[19]  R A Margolin,et al.  Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. , 1985, Archives of general psychiatry.

[20]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[21]  T. Curran,et al.  A protein related to extracellular matrix proteins deleted in the mouse mutant reeler , 1995, Nature.

[22]  Mogens Vestergaard,et al.  A population-based study of measles, mumps, and rubella vaccination and autism. , 2002, The New England journal of medicine.

[23]  R. Tuchman,et al.  Epilepsy and epileptiform EEG: association with autism and language disorders. , 2000, Mental retardation and developmental disabilities research reviews.

[24]  J. Dambrosia,et al.  Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation , 2001, Annals of neurology.

[25]  C. Gillberg,et al.  Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder , 2002, Molecular Psychiatry.

[26]  J H Miles,et al.  Head circumference is an independent clinical finding associated with autism. , 2000, American journal of medical genetics.

[27]  D. X. Freedman,et al.  Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. , 1961, The Journal of pediatrics.

[28]  M S McPeek,et al.  The genetic dissection of complex traits in a founder population. , 2001, American journal of human genetics.

[29]  J. Miles,et al.  Value of a clinical morphology examination in autism. , 2000, American journal of medical genetics.

[30]  C. Quattrocchi,et al.  Reelin Promotes Peripheral Synapse Elimination and Maturation , 2003, Science.

[31]  P. Thuras,et al.  Purkinje Cell Size Is Reduced in Cerebellum of Patients with Autism , 2002, Cellular and Molecular Neurobiology.

[32]  C. B. Smith,et al.  Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Bachevalier.  Brief report: Medial temporal lobe and autism: A putative animal model in primates , 1996, Journal of autism and developmental disorders.

[34]  A. Bailey,et al.  Autism: recent molecular genetic advances. , 2000, Human molecular genetics.

[35]  E. Courchesne,et al.  Hypoplasia of cerebellar vermal lobules VI and VII in autism. , 1988, The New England journal of medicine.

[36]  P. McGuffin,et al.  Psychopathology in the postgenomic era. , 2003, Annual review of psychology.

[37]  L. Wing,et al.  Asperger's syndrome: a clinical account , 1981, Psychological Medicine.

[38]  Eric Schopler,et al.  Diagnosis and Assessment in Autism , 1988 .

[39]  S. Schulz,et al.  Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices , 2002, Biological Psychiatry.

[40]  J. Gilbert,et al.  Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder. , 2000, American journal of medical genetics.

[41]  Carl Feinstein,et al.  Oxytocin and autistic disorder: alterations in peptide forms , 2001, Biological Psychiatry.

[42]  M. Capecchi,et al.  Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hindbrain. , 1993, Development.

[43]  P S Goldman-Rakic,et al.  Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. , 1982, Brain research.

[44]  Yogesh K. Dwivedi,et al.  The phenotypic characteristics of heterozygous reeler mouse. , 1999, Neuroreport.

[45]  E. Fombonne,et al.  Pervasive developmental disorders in preschool children. , 2001, JAMA.

[46]  E Courchesne,et al.  Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. , 2001, Brain : a journal of neurology.

[47]  Scott F. Hall,et al.  Barrel Pattern Formation Requires Serotonin Uptake by Thalamocortical Afferents, and Not Vesicular Monoamine Release , 2001, The Journal of Neuroscience.

[48]  M. Safir,et al.  Developmental Regression in Autism: Maternal Perception , 2000, Journal of autism and developmental disorders.

[49]  C. McDougle,et al.  The pathophysiology and treatment of autism , 2001, Current psychiatry reports.

[50]  L. Wing.  The autistic spectrum , 1997, The Lancet.

[51]  G. Pison,et al.  Peripheral Markers of Serotonergic and Noradrenergic Function in Post-Pubertal, Caucasian Males with Autistic Disorder , 2000, Neuropsychopharmacology.

[52]  J. Barker,et al.  Differential Response of Cortical Plate and Ventricular Zone Cells to GABA as a Migration Stimulus , 1998, The Journal of Neuroscience.

[53]  P. Rodier,et al.  Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei , 1996, The Journal of comparative neurology.

[54]  M. Rutter.  Genetic Studies of Autism: From the 1970s into the Millennium , 2000, Journal of abnormal child psychology.

[55]  S. Deb,et al.  Neuroimaging in autism , 1998, British Journal of Psychiatry.

[56]  Roland R. Lee,et al.  Magnetoencephalographic Patterns of Epileptiform Activity in Children With Regressive Autism Spectrum Disorders , 1999, Pediatrics.

[57]  A. Arkin,et al.  Stochastic mechanisms in gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  N. Delhaye-bouchaud,et al.  Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse. , 1996, Journal of neurogenetics.

[59]  B. Neville.  Magnetoencephalographic Patterns of Epileptiform Activity in Children With Regressive Autism Spectrum Disorders , 1999, Pediatrics.

[60]  P. Huttenlocher,et al.  Regional differences in synaptogenesis in human cerebral cortex , 1997, The Journal of comparative neurology.

[61]  P. Rodier,et al.  Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. , 2000, Teratology.

[62]  U. Schambra,et al.  Morphogenetic roles of acetylcholine. , 1999, Environmental health perspectives.

[63]  S. Baron-Cohen.  The extreme male brain theory of autism , 2002, Trends in Cognitive Sciences.

[64]  T. Curran,et al.  The Reelin Pathway Modulates the Structure and Function of Retinal Synaptic Circuitry , 2001, Neuron.

[65]  P. A. Jacobs,et al.  Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function , 1997, Nature.

[66]  A. Sabrá,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.

[67]  T. Insel,et al.  Species Differences in Central Oxytocin Receptor Gene Expression: Comparative Analysis of Promoter Sequences , 1996, Journal of neuroendocrinology.

[68]  D. Swaab,et al.  Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. , 1995, The Journal of clinical endocrinology and metabolism.

[69]  E R Martin,et al.  Association Analysis of Chromosome 15 GABAA Receptor Subunit Genes in Autistic Disorder , 2001, Journal of neurogenetics.

[70]  D. Cohen,et al.  The Hyperserotonemia of Autism a , 1990, Annals of the New York Academy of Sciences.

[71]  Stephen J. Guter,et al.  Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. , 1998, American journal of human genetics.

[72]  Marshall B. Jones,et al.  Nonfamiliality of the sex ratio in autism. , 1996, American journal of medical genetics.

[73]  N J Cox,et al.  Evidence of linkage between the serotonin transporter and autistic disorder , 1997, Molecular Psychiatry.

[74]  U. Frith,et al.  Autism and Asperger Syndrome , 1992 .

[75]  A. Kriegstein,et al.  Clusters of coupled neuroblasts in embryonic neocortex. , 1991, Science.

[76]  S. Smalley.  Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. , 1997, American journal of human genetics.

[77]  A. Arkin,et al.  It's a noisy business! Genetic regulation at the nanomolar scale. , 1999, Trends in genetics : TIG.

[78]  E. Fombonne.  Is there an epidemic of autism? , 2001, Pediatrics.

[79]  P. Gaspar,et al.  Transient Uptake and Storage of Serotonin in Developing Thalamic Neurons , 1996, Neuron.

[80]  H. Asperger,et al.  Die „Autistischen Psychopathen” im Kindesalter , 1944, Archiv für Psychiatrie und Nervenkrankheiten.

[81]  E. Emamian,et al.  Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice , 1999, Molecular Psychiatry.

[82]  D. Cohen,et al.  Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia , 2002, Molecular Psychiatry.

[83]  J. Fryns,et al.  ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. , 2002, Human molecular genetics.

[84]  Richard Paylor,et al.  Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1 , 1997, Cell.

[85]  F. Volkmar,et al.  Language regression in childhood. , 2001, Pediatric neurology.

[86]  F. Muratori,et al.  Increased density of the platelet serotonin transporter in autism. , 2000, Pharmacopsychiatry.

[87]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[88]  T. Insel,et al.  A neurobiological basis of social attachment. , 1997, The American journal of psychiatry.

[89]  T. Hashimoto,et al.  Development of the brainstem and cerebellum in autistic patients , 1995, Journal of autism and developmental disorders.

[90]  S Arndt,et al.  An MRI study of the corpus callosum in autism. , 1997, The American journal of psychiatry.

[91]  P. Rodier,et al.  Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. , 2000, Neurotoxicology and teratology.

[92]  Robert Plomin,et al.  Genetics and general cognitive ability , 1999, Nature.

[93]  J. Buxbaum,et al.  Association between a GABRB3 polymorphism and autism , 2002, Molecular Psychiatry.

[94]  Masakazu Konishi,et al.  Decrystallization of adult birdsong by perturbation of auditory feedback , 1999, Nature.

[95]  Paul D Griffiths,et al.  Association of tuberous sclerosis of temporal lobes with autism and atypical autism , 1997, The Lancet.

[96]  F. Volkmar,et al.  Whole blood serotonin in autistic and normal subjects. , 1987, Journal of child psychology and psychiatry, and allied disciplines.

[97]  R. Rothermel,et al.  Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children , 1999, Annals of neurology.

[98]  T. Insel,et al.  The social deficits of the oxytocin knockout mouse , 2002, Neuropeptides.

[99]  Michael S. Brainard,et al.  What songbirds teach us about learning , 2002, Nature.

[100]  E. Costa,et al.  Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  E. Cook,et al.  Genetics of autism. , 2001, Child and adolescent psychiatric clinics of North America.

[102]  R. Murray,et al.  Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder , 1998, Molecular Psychiatry.

[103]  Andrew E. Switala,et al.  Minicolumnar pathology in autism , 2002, Neurology.

[104]  N. Delhaye-bouchaud,et al.  Cerebellar purkinje cell loss during life span of the heterozygous Staggerer mouse (Rora+/Rorasg) is gender‐related , 1999, The Journal of comparative neurology.

[105]  D. Grayson,et al.  Reelin gene alleles and susceptibility to autism spectrum disorders , 2002, Molecular Psychiatry.

[106]  S. Shapiro,et al.  Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice. , 2000, American journal of respiratory cell and molecular biology.

[107]  M. Polanyi.  Life's irreducible structure. Live mechanisms and information in DNA are boundary conditions with a sequence of boundaries above them. , 1968, Science.

[108]  D. Chugani.  Role of altered brain serotonin mechanisms in autism , 2002, Molecular Psychiatry.

[109]  C. Gillberg,et al.  Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism , 2002, Molecular Psychiatry.

[110]  Stephen J. Guter,et al.  Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder , 2002, Molecular Psychiatry.

[111]  Karel Svoboda,et al.  Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.

[112]  A. Sandler.  The 2nd to 4th digit ratio and autism. , 2001 .

[113]  M. Cuccaro,et al.  Autism and maternally derived aberrations of chromosome 15q. , 1998, American journal of medical genetics.

[114]  J. Barker,et al.  GABA(B) receptors mediate motility signals for migrating embryonic cortical cells. , 2001, Cerebral cortex.

[115]  S. Folstein,et al.  Evidence supporting WNT2 as an autism susceptibility gene. , 2001, American journal of medical genetics.

[116]  Patricia Gaspar,et al.  Lack of Barrels in the Somatosensory Cortex of Monoamine Oxidase A–Deficient Mice: Role of a Serotonin Excess during the Critical Period , 1996, Neuron.

[117]  J. Lübke,et al.  Axonal Projection, Input and Output Synapses, and Synaptic Physiology of Cajal–Retzius Cells in the Developing Rat Neocortex , 2002, The Journal of Neuroscience.

[118]  A Benner,et al.  Serotonin transporter (5-HTT) gene variants associated with autism? , 1997, Human molecular genetics.

[119]  N. Minshew,et al.  MRI volumes of amygdala and hippocampus in non–mentally retarded autistic adolescents and adults , 1999, Neurology.

[120]  S. Scherer,et al.  Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. , 2001, American journal of human genetics.

[121]  Walter Fontana,et al.  Genetic networks. Small numbers of big molecules. , 2002, Science.

[122]  D. Barr,et al.  Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. , 2001, Environmental health perspectives.

[123]  W. Fontana,et al.  Small Numbers of Big Molecules , 2002, Science.

[124]  M. Spence,et al.  Evidence for autosomal recessive inheritance in 46 families with multiple incidences of autism. , 1985, The American journal of psychiatry.

[125]  L. Kanner.  Autistic disturbances of affective contact. , 1968, Acta paedopsychiatrica.

[126]  I. Rapin,et al.  Autistic regression and disintegrative disorder: how important the role of epilepsy? , 1995, Seminars in pediatric neurology.

[127]  J C Olivo,et al.  Two rhombomeres are altered in Hoxa-1 mutant mice. , 1993, Development.

[128]  S. Folstein,et al.  Platelet serotonin, a possible marker for familial autism , 1991, Journal of autism and developmental disorders.

[129]  T. Kemper,et al.  Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.

[131]  S. Folstein,et al.  Genetics of austim: complex aetiology for a heterogeneous disorder , 2001, Nature Reviews Genetics.

[132]  E K Perry,et al.  Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. , 2001, The American journal of psychiatry.

[133]  A. Bailey,et al.  A clinicopathological study of autism. , 1998, Brain : a journal of neurology.

[134]  Joseph Piven,et al.  An MRI study of the basal ganglia in autism , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[135]  J. Gilbert,et al.  Genomic screen and follow-up analysis for autistic disorder. , 2002, American journal of medical genetics.

[136]  Flavio Keller,et al.  Reelin Is a Serine Protease of the Extracellular Matrix* , 2002, The Journal of Biological Chemistry.

[137]  S. Fatemi,et al.  Reduced Blood Levels of Reelin as a Vulnerability Factor in Pathophysiology of Autistic Disorder , 2002, Cellular and Molecular Neurobiology.

[138]  I. Black,et al.  A single peripheral injection of basic fibroblast growth factor (bFGF) stimulates granule cell production and increases cerebellar growth in newborn rats. , 2001, Journal of neurobiology.

[139]  R. Rhoades,et al.  The source of the transient serotoninergic input to the developing visual and somatosensory cortices in rat , 1991, Neuroscience.

[140]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[141]  Research strategies in autism: a story with two sides , 2001, Current opinion in neurology.

[142]  N. Minshew,et al.  Brain Volume in Autism , 2001, Journal of child neurology.

[143]  R. Rothermel,et al.  Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction , 2001, Neurology.